HighTower Advisors’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$400K Buy
10,236
+1,326
+15% +$49.2K ﹤0.01% 2947
2026
Q1
$357K Buy
+8,910
New +$422K ﹤0.01% 3005
2025
Q4
Sell
-9,763
Closed -$436K 3901
2025
Q3
$436K Buy
9,763
+160
+2% +$7.66K ﹤0.01% 2722
2025
Q2
$462K Sell
9,603
-730
-7% -$31.8K ﹤0.01% 2594
2025
Q1
$415K Sell
10,333
-7,301
-41% -$307K ﹤0.01% 2612
2024
Q4
$808K Sell
17,634
-3,882
-18% -$174K ﹤0.01% 2118
2024
Q3
$1.01M Sell
21,516
-4,474
-17% -$204K ﹤0.01% 1925
2024
Q2
$1.1M Buy
25,990
+5,164
+25% +$226K ﹤0.01% 1795
2024
Q1
$924K Buy
+20,826
New +$949K ﹤0.01% 1853
2023
Q4
Sell
-10,553
Closed -$458K 3811
2023
Q3
$458K Buy
10,553
+209
+2% +$9.74K ﹤0.01% 2288
2023
Q2
$492K Buy
+10,344
New +$499K ﹤0.01% 2212
2022
Q3
Sell
-4,520
Closed -$225K 3352
2022
Q2
$225K Sell
4,520
-295
-6% -$14.4K ﹤0.01% 2555
2022
Q1
$249K Sell
4,815
-2,280
-32% -$118K ﹤0.01% 2666
2021
Q4
$418K Buy
7,095
+1,920
+37% +$110K ﹤0.01% 2274
2021
Q3
$283K Buy
5,175
+463
+10% +$25.8K ﹤0.01% 2451
2021
Q2
$242K Sell
4,712
-132
-3% -$6.82K ﹤0.01% 2533
2021
Q1
$250K Buy
4,844
+411
+9% +$22.6K ﹤0.01% 2428
2020
Q4
$250K Buy
4,433
+202
+5% +$10.8K ﹤0.01% 2056
2020
Q3
$234K Buy
+4,231
New +$219K ﹤0.01% 1990
2019
Q4
Sell
-11,157
Closed -$387K 2503
2019
Q3
$387K Buy
11,157
+327
+3% +$12.6K ﹤0.01% 1643
2019
Q2
$466K Sell
10,830
-21,082
-66% -$873K ﹤0.01% 1546
2019
Q1
$1.38M Buy
31,912
+23,734
+290% +$955K 0.01% 1003
2018
Q4
$298K Sell
8,178
-1,750
-18% -$65K ﹤0.01% 1603
2018
Q3
$400K Buy
9,928
+3,825
+63% +$153K ﹤0.01% 1571
2018
Q2
$233K Buy
+6,103
New +$225K ﹤0.01% 1818

Other funds holding QGEN

HighTower Advisors's QGEN Position: Q2 2026 in Review

HighTower Advisors increased its Qiagen (QGEN) stake by 15% in Q2 2026, buying an estimated $49.2K and bringing the position to 10,236 shares worth $400K. The position accounts for ﹤0.01% of the portfolio, ranked #2947.

HighTower Advisors first reported a position in QGEN in Q2 2018 and has held it in 25 quarters since. The position peaked at $1.38M in Q1 2019. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • HighTower Advisors held 10,236 shares of Qiagen worth $400K as of Q2 2026.
  • HighTower Advisors bought 1,326 Qiagen shares in Q2 2026, an estimated $49.2K.
  • Qiagen made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #2947 holding.
  • HighTower Advisors first reported a position in Qiagen in Q2 2018 and has held it in 25 quarters since.
  • HighTower Advisors's Qiagen position peaked at $1.38M in Q1 2019.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.